HealthEquity (FRA:2HE) EPS (Basic): €2.30 (TTM As of Apr. 2026)


FRA:2HE HealthEquity Inc FRA:2HE
93 GF Score
Price €74.00
GF Value €87.87
! 1 Warning Sign
View Full Analysis

What is HealthEquity EPS (Basic)?

HealthEquity FRA:2HE +2.07% 93 EPS (Basic) is €2.30 as of Apr. 2026. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €87.87. The stock has 1 warning sign investors should review.

HealthEquity's basic earnings per share (Basic EPS) for the three months ended in Apr. 2026 was €0.70. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2026 was €2.30.

HealthEquity's EPS (Diluted) for the three months ended in Apr. 2026 was €0.70. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was €2.29.

HealthEquity's EPS without NRI for the three months ended in Apr. 2026 was €1.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was 3.66.

During the past 12 months, HealthEquity's average EPS without NRIGrowth Rate was 29.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 43.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 23.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, HealthEquity's highest 3-Year average EPS without NRI Growth Rate was 57.80% per year. The lowest was -7.70% per year. And the median was 33.90% per year.

HealthEquity  (FRA:2HE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

HealthEquity EPS (Basic) Related Terms

HealthEquity EPS (Basic) Historical Data

* Premium members only.

The historical data trend for HealthEquity's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity EPS (Basic) Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.47 -0.29 0.60 1.07 2.13

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.59 0.52 0.49 0.70
FRA:2HE
93GF Score
HealthEquity Inc FRA:2HE
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

HealthEquity's Basic EPS for the fiscal year that ended in Jan. 2026 is calculated as

Basic EPS (A: Jan. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(183.136-0)/86.132
=2.13

HealthEquity's Basic EPS for the quarter that ended in Apr. 2026 is calculated as

Basic EPS (Q: Apr. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(59.352-0)/84.413
=0.70

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €2.30 mean?
HealthEquity (FRA:2HE) has a EPS (Basic) of €2.30 as of Apr. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on HealthEquity and its competitors.
Is HealthEquity's EPS (Basic) too high?
HealthEquity's current EPS (Basic) is €2.30. Overall, HealthEquity has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's EPS (Basic) compare to TEM and HNGE?
HealthEquity's EPS (Basic) of €2.30 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on HealthEquity and its competitors. HealthEquity's current EPS (Basic) is €2.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current EPS (Basic) of €2.30. The stock's GF Value™ is €87.87, compared to a current price of €74.00 — trading 15.8% below its estimated fair value. The current EPS (Basic) is €2.30. HealthEquity's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current EPS (Basic) is €2.30 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €74.00 is trading 15.8% below its estimated GF Value™ of €87.87.

Key valuation signals for FRA:2HE:

  • EPS (Basic): €2.30
  • GF Value™: €87.87 vs. price of €74.00 (15.8% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score

Get the complete analysis for FRA:2HE

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.00
Price
€87.87
GF Value